Moleculin Reports Full Year Financial Results and Provides Programs Update

Go back to Moleculin Reports Full Year Financial Results and Provides Programs Update
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.93 +0.18 (6.55%)
Previous Close $2.75    52 Week High $9.58 
Open $2.61    52 Week Low $2.34 
Day High $2.94    P/E N/A 
Day Low $2.61    EPS $-0.34 
Volume 909,123